(Ivanhoe Newswire) — Immunosuppressive medications used to treat patients with Inflammatory Bowel Disease (IBD) are now linked to increasing a patient’s risk of developing non-melanoma skin cancer (NMSC). Researchers at the University of North Read on

This entry was posted on Friday, November 6th, 2009 at 10:20 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.